Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.

Held G, Wadle A, Dauth N, Stewart-Jones G, Sturm C, Thiel M, Zwick C, Dieckmann D, Schuler G, Hoogenboom HR, Lévy F, Cerundolo V, Pfreundschuh M, Renner C.

Eur J Immunol. 2007 Jul;37(7):2008-17. Erratum in: Eur J Immunol. 2008 May;38(5):1465-6.

2.

Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases.

Hölsken A, Eyüpoglu IY, Lueders M, Tränkle C, Dieckmann D, Buslei R, Hahnen E, Blümcke I, Siebzehnrübl FA.

Acta Neuropathol. 2006 Aug;112(2):205-15. Epub 2006 Jun 14.

PMID:
16773328
3.

Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells.

Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M.

J Immunol. 2006 Mar 1;176(5):3215-22. Erratum in: J Immunol. 2012 Oct 1;189(7):3779.

4.

Artesunate in the treatment of metastatic uveal melanoma--first experiences.

Berger TG, Dieckmann D, Efferth T, Schultz ES, Funk JO, Baur A, Schuler G.

Oncol Rep. 2005 Dec;14(6):1599-603.

PMID:
16273263
5.
6.

Optimizing the exogenous antigen loading of monocyte-derived dendritic cells.

Dieckmann D, Schultz ES, Ring B, Chames P, Held G, Hoogenboom HR, Schuler G.

Int Immunol. 2005 May;17(5):621-35. Epub 2005 Apr 11. Retraction in: Int Immunol. 2012 Jun;24(6):401.

PMID:
15824067
7.

Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.

Schaft N, Dörrie J, Thumann P, Beck VE, Müller I, Schultz ES, Kämpgen E, Dieckmann D, Schuler G.

J Immunol. 2005 Mar 1;174(5):3087-97. Erratum in: J Immunol. 2005 May 1;174(9):5884.

8.

Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris.

Veldman C, Höhne A, Dieckmann D, Schuler G, Hertl M.

J Immunol. 2004 May 15;172(10):6468-75. Erratum in: J Immunol. 2012 Oct 1;189(7):3778.

9.

Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.

Nettelbeck DM, Rivera AA, Kupsch J, Dieckmann D, Douglas JT, Kontermann RE, Alemany R, Curiel DT.

Int J Cancer. 2004 Jan 1;108(1):136-45.

10.

Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma.

Nettelbeck DM, Rivera AA, Davydova J, Dieckmann D, Yamamoto M, Curiel DT.

Melanoma Res. 2003 Jun;13(3):287-92.

PMID:
12777984
11.

Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G.

J Exp Med. 2002 Jul 15;196(2):247-53. Erratum in: J Exp Med 2002 Aug 19;196(4):559. J Exp Med 2002 Sep 16;196(6):867.

12.

TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.

Chames P, Willemsen RA, Rojas G, Dieckmann D, Rem L, Schuler G, Bolhuis RL, Hoogenboom HR.

J Immunol. 2002 Jul 15;169(2):1110-8.

13.

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.

Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G.

J Exp Med. 2001 Jun 4;193(11):1303-10.

14.

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells.

Schuler-Thurner B, Dieckmann D, Keikavoussi P, Bender A, Maczek C, Jonuleit H, Röder C, Haendle I, Leisgang W, Dunbar R, Cerundolo V, von Den Driesch P, Knop J, Bröcker EB, Enk A, Kämpgen E, Schuler G.

J Immunol. 2000 Sep 15;165(6):3492-6.

15.

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Thurner B, Haendle I, Röder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Bröcker EB, Steinman RM, Enk A, Kämpgen E, Schuler G.

J Exp Med. 1999 Dec 6;190(11):1669-78.

16.

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.

Thurner B, Röder C, Dieckmann D, Heuer M, Kruse M, Glaser A, Keikavoussi P, Kämpgen E, Bender A, Schuler G.

J Immunol Methods. 1999 Feb 1;223(1):1-15. Review. Erratum in: J Immunol Methods 1999 Apr 22;224(1-2):211.

PMID:
10037230
17.
18.

Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells.

Nitschke M, Sohn K, Dieckmann D, Gibbs BF, Wolff HH, Amon U.

Arch Dermatol Res. 1996 Jul;288(8):463-8.

PMID:
8844126
19.

Heterogeneity of human skin mast cells and human basophils. I. Pharmacological experiments with activators and inhibitors of protein kinase C.

Amon U, Dieckmann D, Nitschke M, von Stebut E, Gibbs BF, Wolff HH.

Skin Pharmacol. 1996;9(3):211-20.

PMID:
8737919
20.

[The role of basophilic leukocytes in inflammatory skin diseases].

Amon U, Dieckmann D, Nitschke M, Wehrhahn C, Wolff HH.

Hautarzt. 1995 Apr;46(4):234-9. Review. German.

PMID:
7540604
21.

Activation and inhibition of mediator release from skin mast cells: a review of in vitro experiments.

Amon U, Nitschke M, Dieckmann D, Gibbs BF, Wehrhahan C, Wolff HH.

Clin Exp Allergy. 1994 Dec;24(12):1098-104. Review. No abstract available.

PMID:
7889422
22.

[Vibration and its effect on the human. Review].

Dieckmann D, Meyer H.

Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie. 1982 Oct;32(10):374-8. German. No abstract available.

PMID:
7180226
23.

[Vibrations in motor vehicles].

Dieckmann D.

Hefte Unfallheilkd. 1966;87:214-9. German. No abstract available.

PMID:
5991089
24.
25.

[A mechanical model for the hand-arm system set in motion by oscillation].

DIECKMANN D.

Int Z Angew Physiol. 1958;17(2):125-32. German. No abstract available.

PMID:
13549074
26.

[Influence of horizontal mechanical swinging on man].

DIECKMANN D.

Int Z Angew Physiol. 1958;17(1):83-100. English, German. No abstract available.

PMID:
13549069
27.

[Mechanical models for the vertically swinging human body].

DIECKMANN D.

Int Z Angew Physiol. 1958;17(1):67-82. German. No abstract available.

PMID:
13549068
28.

[Influence of vertical mechanical oscillations in man].

DIECKMANN D.

Int Z Angew Physiol. 1957;16(6):519-64. German. No abstract available.

PMID:
13525032
29.

[Prolonged analgesia by procainebutoform].

DIECKMANN DG, BASSOT J, ORGEVAL C.

Gaz Med Fr. 1953 Dec;60(24):1477-80. Undetermined Language. No abstract available.

PMID:
13142251
30.

[New occlusive complications caused by absorption of a carboxy-methylcellulose cathartic].

ISELIN M, DIECKMANN DG.

Mem Acad Chir (Paris). 1952 Jun 25-Jul 9;78(22-24):682-4. Undetermined Language. No abstract available.

PMID:
12992597

Supplemental Content

Loading ...
Support Center